Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Immunodermatology Market

Immunodermatology Market by Type (Systemic sclerosis, Dermatomyositis, Psoriasis, Vitiligo, Alopecia areata, Lichen sclerosus, Allergic Dermatitis, Atopic Dermatitis, Lupus erythematosus, Blistering diseases, and Connective tissue diseases), Diagnosis (Immunofluorescence Testing, Biopsy, and Blood Test), Therapy (Drug Therapy, Intensed Pulsed Light (IPL)Therapy, Stem Cell Therapy, and Gene Therapy), and Mode of Administration (Oral, Topical, and Intravenous): Global Opportunity Analysis and Industry Forecast, 2021–2030

A12596
Pages: NA
Oct 2021 | 91 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Immunodermatology Market

Request Now !

Immunodermatology is a medical specialization that concentrates on diagnosing and treating skin disorders characterized by responses that influence the body's immune system. Immunodermatology testing is essential in the diagnosis and treatment of many diseases afflicting the epithelial organs including the skin, intestines, respiratory tract, and mucous membranes. Skin fights antigens on T cells and produces various types of cytokines because the skin is the body's first defective organ. From newborns to the elderly, skin diseases affect patients at any time, and they can be chronic or acute, genetic or conditional, and painful or painless. Numerous factors including the surge in demand for early diagnosis of skin conditions, increase in geriatric population, enhanced health insurance, and raised disposal income are linked with the expansion of immunodermatology market size.

Market Scope and Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2021–2030

 Base Year Considered

 2020

 Forecast Period

 2021–2030

 Forecast Unit

 Value (USD)

 Segments Covered

 Product Type, Application, End User, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, and LAMEA

 Companies Covered

Novartis, Abbvie, Valeant Pharmaceuticals, Bausch Health, Glenmark Pharmaceuticals Inc., Astellas Pharma, Novopharm Limited, Aspen Pharmacare Inc., Prometheus Laboratories, Taro Pharmaceuticals Inc., and Nucare Pharmaceuticals Inc.


COVID-19 Impact analysis

COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the immunodermatology market.

Top Impacting Factors

  • Increase in cases of cardiovascular diseases, surge in geriatric populations, rise in demand for minimally invasive procedure & advanced cardiovascular treatment and procedures such as balloon angioplasty are factors that drive the growth of the angioplasty balloons market
  • In addition, increase in healthcare expenditure; availability of skilled professionals; collaborations & partnerships between key players to facilitate drug development; rise in R&D activities to improve quality of drugs; launch of novel developed drug in market; and technological development such as imaging technologies, drug-eluting, and cutting balloons are some factors, which boost the market growth for angioplasty balloons
  • However, lack of knowledge for proper handling of the device as well as side effects and associated complications hinder the market growth.
  • Contrarily, favorable reimbursement policies and support from government for regulatory approval present new pathways in the industry

Market Trends

New product launches to flourish the market

In May 2019, UCB, a global biopharmaceutical company, received FDA approval for the UCB’s tumor necrosis factor (TNF) inhibitor Cimzia (certolizumab pegol) to treat adults with moderate-to-severe plaque psoriasis. This approval indicates UCB’s path into the immuno-dermatology market.

In December 2020, Arcutis Biotherapeutics, Inc., a late-stage biopharmaceutical company announced that they are focusing on the development and commercialized treatments for unmet needs in immune-mediated dermatological diseases and conditions. The robust pipeline involves 4 development programs addressing 7 dermatological diseases, which includes 3 programs in Phase 2 or Phase 3 for 5 different indications.

Key Segments Covered

Segment

Subsegment

 Type

    • Systemic sclerosis
    • Dermatomyositis
    • Psoriasis
  • Vitiligo
  • Alopecia areata
  • Lichen sclerosus
  • Allergic Dermatitis
  • Atopic Dermatitis
  • Lupus erythematosus
  • Blistering diseases
  • Connective tissue diseases

 Diagnosis

  • Immunofluorescence Testing
    • Direct
    • Indirect
  • Biopsy
  • Blood Test

 Therapy

  • Drug Therapy
    • Corticosteroids
    • Immunosuppressant
    • Calcineurin Inhibitors
    • TNF Alfa Inhibitors
    • Interleukin Inhibitors
    • Antibiotics
  • Intensed Pulsed Light (IPL)Therapy
  • Stem Cell Therapy
  • Gene Therapy

 Mode of Administration

  • Oral
  • Topical
  • Intravenous

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA


Key Benefits of the Report

  • This study presents the analytical depiction of the immunodermatology industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the immunodermatology market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the immunodermatology market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed immunodermatology market analysis based on competitive intensity and how the competition will take shape in coming years

Questions answered in the immunodermatology  Report

  • Which are the leading players active in the immunodermatology market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is "Immunodermatology"?
  • What is "Immunodermatology" Market prediction in the future?
  • Who are the leading global players in the "Immunodermatology" Market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the "Immunodermatology" Market report?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Immunodermatology Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers